The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes with CPX-351 versus 7+3 by baseline bone marrow (BM) blast percentage in older adults with newly diagnosed high-risk/secondary acute myeloid leukemia (sAML).
 
Ellen K. Ritchie
Consulting or Advisory Role - Celgene; Incyte; Novartis; Pfizer
Speakers' Bureau - ARIAD; Celgene; Incyte; Novartis; Pfizer
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals; Novartis (Inst); NS Pharma (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Tara L. Lin
Honoraria - Jazz Pharmaceuticals
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bio-Path Holdings, Inc (Inst); Celator (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Imago Pharma (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Mateon Therapeutics (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Prescient Therapeutics (Inst); Seagen (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)
 
Laura F. Newell
No Relationships to Disclose
 
Robert K. Stuart
Honoraria - Sunesis Pharmaceuticals
Consulting or Advisory Role - Sunesis Pharmaceuticals
Research Funding - Agios (Inst); Astellas Pharma (Inst); Bayer (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Sunesis Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Sunesis Pharmaceuticals
 
Scott R. Solomon
No Relationships to Disclose
 
Richard M. Stone
Honoraria - DAVA Pharmaceuticals; Medscape; Prime Oncology; Research to Practice
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; argenx; Arog; Astellas Pharma; AstraZeneca; Celgene; Celgene/Jazz; Cornerstone Pharmaceuticals; Macrogenics; Novartis; Otsuka; Pfizer; Roche/Genentech; Stemline Therapeutics; Takeda
Research Funding - Abbvie/Genentech (Inst); Agios (Inst); Novartis (Inst)
 
Gary J. Schiller
Consulting or Advisory Role - Astellas Pharma
Research Funding - Astellas Pharma (Inst); Bluebird Bio (Inst)
 
Matthew Joseph Wieduwilt
Stock and Other Ownership Interests - Reata Pharmaceuticals
Research Funding - ADC Therapeutics (Inst); Amgen (Inst); Cantex (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Shire (Inst); Sigma-Tau (Inst)
 
Daniel H. Ryan
Stock and Other Ownership Interests - Abbvie
Patents, Royalties, Other Intellectual Property - University of Rochester
 
Robert J Ryan
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Michael Chiarella
Employment - Celator; Jazz Pharmaceuticals
Stock and Other Ownership Interests - Celator; Jazz Pharmaceuticals
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Takeda
Research Funding - Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Immunogen (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)